New Biotech Billionaire Minted In Caris Life Sciences IPO

Caris Life Sciences raises $494 million in IPO

Caris Life Sciences Shares Climb After $494 Million IPO

Caris Life Sciences Inc. jumped as much as 40% after the health-care company raised $494 million in a US initial public offering that priced above the top of its marketed range.

Irving-based Caris Life Sciences raises $494 million in IPO

Caris Life Sciences Inc., a health care company that uses technology to help diagnose and treat cancer, raised $494 million in a U.S. initial public offering...

Live Nasdaq Composite: Markets Hold Steady on Fed Day as Mideast Tensions Boil

Live Updates Live Coverage Has Ended Today's IPO Receives Warm Welcome 12:53 pm by Gerelyn Terzo The markets rolled out the welcome mat for healthcare stock Caris Life Sciences (Nasdaq: CAI) today, which makes its debut on the Nasdaq. After pricing the IPO at $21 per share, Caris Life has climbed over 32% to $27.85 per share. Caris Life uses AI algorithms in blood tests to diagnose early detection of diseases like breast cancer. The Nasdaq Co…

New Biotech Billionaire Minted In Caris Life Sciences IPO

With the successful IPO of Caris Life Sciences makes its founder David Dean Halbert worth an estimated $3.3 billion.

Caris Life Sciences CEO on IPO debut, using AI to fight against cancer

David Dean Halbert, Caris Life Sciences chairman, founder and CEO, joins 'Squawk Box' to discuss the company's IPO debut, how the company uses AI technology to help diagnose and treat cancer,